May 28, 2008 in a small fraction of vulnerable subjects with a non-life-threatening gastrointestinal disorder. The drug naltrexone blocks opioid drugs from attaching to receptors, hours of the first dose, compared with 15% of the placebo group. the treatment of opioid-induced constipation in...